Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of METAglut1 Diagnostic Test Performances in Patients With a Clinical Suspicion of GLUT1 Deficiency Syndrome

NCT03722212 is registered in ClinicalTrials.gov with METAFORA biosystems as lead sponsor.

NCT NCT03722212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03722212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of METAglut1 Diagnostic Test Performances in Patients With a Clinical Suspicion of GLUT1 Deficiency Syndrome
Lead sponsor
METAFORA biosystems
Phase
Not applicable
Overall status
Completed
Start date
September 24, 2018
Completion date
July 9, 2021
Enrollment
636 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia, de vivo disease, glut1 deficiency syndrome, intellectual disability, movement disorders, seizures